APA引文

Shi, H., Xu, J., Lang, X., Wu, H. E., Xiu, M. H., Zhang, X. Y., & Zhang, X. Y. (2022). Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial. Frontiers Media S.A.

Citação norma Chicago

Shi, Hui, Jing Xu, Xiaoe Lang, Hanjing Emily Wu, Mei Hong Xiu, Xiang Yang Zhang, and Xiang Yang Zhang. Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial. Frontiers Media S.A, 2022.

MLA引文

Shi, Hui, et al. Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial. Frontiers Media S.A, 2022.